Sylvia A. Holden

5.3k citations
85 papers · 4.4k indexed · 2 hit papers · h-index 31
Topics
Cancer, Hypoxia, and Metabolism (24 papers)Cancer therapeutics and mechanisms (10 papers)Cancer-related Molecular Pathways (10 papers)

In The Last Decade

Sylvia A. Holden

84 papers receiving 4.3k citations

Hit Papers

Differentiation and reversal of malignant changes in colo...199820262007201619981998250500750

Peers

Sylvia A. Holden
Comparison fields: 5 of 112
  • Molecular Biology 2.8k
  • Cancer Research 1.6k
  • Oncology 1.4k
  • Pharmacology 507
  • Pulmonary and Respiratory Medicine 398
Replace Stephen Gately with:
Stephen Gately United States
David G. Menter United States
William P. Tong United States
Steffen Hauptmann Germany
David J. Chaplin United Kingdom
Oliver Stoeltzing United States
Keizo Dono Japan
Nora M. Navone United States
Dvorit Samid United States
Volker Gekeler Germany
Sylvia A. Holden relative to Stephen Gately United States Stephen Gately's profile →
Citations per field
00.5×1.5×2.1×
Stephen Gately · 1×
Citations per year

Countries citing papers authored by Sylvia A. Holden

Since Specialization
Citations

This map shows the geographic impact of Sylvia A. Holden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sylvia A. Holden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sylvia A. Holden more than expected).

Fields of papers citing papers by Sylvia A. Holden

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sylvia A. Holden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sylvia A. Holden. The network helps show where Sylvia A. Holden may publish in the future.

Co-authorship network of co-authors of Sylvia A. Holden

This figure shows the co-authorship network connecting the top 25 collaborators of Sylvia A. Holden. A scholar is included among the top collaborators of Sylvia A. Holden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sylvia A. Holden. Sylvia A. Holden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1
Differentiation and reversal of malignant changes in colon cancer through PPARγbreakdown →
865
2 11
3 24
4 2
5 69
6 14
7 35
8 56
9 192
10 10
11 19
12 10
13 27
14 12
15 10
16 8
17 2
18
Cross-resistance and glutathione-S-transferase-pi levels among four human melanoma cell lines selected for alkylating agent resistance.
82
19 17
20 42

About Sylvia A. Holden

Sylvia A. Holden is a scholar working on Cancer Research, Oncology and Biotechnology, having authored 85 papers that have together received 4.4k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (24 papers), Cancer therapeutics and mechanisms (10 papers) and Cancer-related Molecular Pathways (10 papers). The work is most often cited by research in Cancer Research (1.6k citations), Oncology (1.4k citations) and Molecular Biology (2.8k citations). Sylvia A. Holden has collaborated with scholars based in United States, Germany and Japan. Frequent co-authors include Beverly A. Teicher, Terence S. Herman, E Frei, H. Phillip Koeffler, Samuel Singer, Lan Bo Chen, Daniel J. DeAngelo, Pasha Sarraf, Elisabetta Mueller and Christopher D.�M. Fletcher. Their work appears in journals such as Science, Journal of Clinical Investigation and Nature Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026